1. Secondary lymphedema from cancer therapy
- Author
-
Jay W. Granzow, Saskia R.J. Thiadens, Paula Stewart, and M. Bernas
- Subjects
0301 basic medicine ,Cancer Research ,medicine.medical_specialty ,Secondary lymphedema ,medicine.medical_treatment ,Cancer therapy ,Cancer metastasis ,03 medical and health sciences ,0302 clinical medicine ,hemic and lymphatic diseases ,International congress ,medicine ,Intensive care medicine ,Rehabilitation ,business.industry ,Cancer ,General Medicine ,medicine.disease ,humanities ,body regions ,030104 developmental biology ,Lymphedema ,Oncology ,030220 oncology & carcinogenesis ,medicine.symptom ,business ,Patient education - Abstract
This manuscript is a summary of findings focusing on various aspects of secondary lymphedema specifically as a sequelae of treatment for cancer. The topic was addressed at a session held during the 8th International Congress on Cancer Metastasis that was unique a for the inclusion of patients with lymphedema and therapists joining physicians, healthcare professionals, and researchers in an effort to give an overview of secondary lymphedema following cancer therapy as well as highlighting the unknowns in the field. Lymphedema is defined and both diagnosis and incidence of cancer-related lymphedema are explored. Further, exploration of imaging options for lymphedema and information on the genetic research for patients with cancer-related secondary lymphedema are presented. Patient education and early detection methods are then explored followed by conservative treatment. Finally, an examination of surgical treatment methods available for patients with lymphedema is covered. Overall, this manuscript presents valuable information and updates for those not familiar with incidence, diagnosis, early detection, and rehabilitation of patients with cancer-related secondary lymphedema.
- Published
- 2021
- Full Text
- View/download PDF